{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:07:25Z","timestamp":1790716045626,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ontario Graduate Scholarships"},{"name":"Mitacs scholarship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.neuroscience.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T22:46:19Z","timestamp":1550875579000},"page":"130-140","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Alterations in Hippocampal Inhibitory Synaptic Transmission in the R6\/2 Mouse Model of Huntington\u2019s Disease"],"prefix":"10.1016","volume":"404","author":[{"given":"Zahra","family":"Dargaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Serranilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janeane","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie A.","family":"Woodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2019.02.007_bb0005","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/jnnp-2015-312413","article-title":"Hippocampal dysfunction defines disease onset in Huntington\u2019s disease","volume":"87","author":"Begeti","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0015","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1023\/A:1012324231897","article-title":"Hippocampal GABAergic interneurons: a physiological perspective","volume":"26","author":"Buzs\u00e1ki","year":"2001","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington\u2019s disease: reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0025","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1523\/JNEUROSCI.2137-12.2013","article-title":"Multiple sources of striatal inhibition are differentially affected in Huntington\u2019s disease mouse models","volume":"33","author":"Cepeda","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0030","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1523\/JNEUROSCI.0388-12.2012","article-title":"R6\/2 Huntington\u2019s disease mice develop early and progressive abnormal brain metabolism and seizures","volume":"32","author":"Cepeda-Prado","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0035","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1073\/pnas.94.6.2665","article-title":"Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses","volume":"94","author":"Choi","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0040","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","article-title":"Alterations in cortical excitation and inhibition in genetic mouse models of Huntington\u2019s disease","volume":"29","author":"Cummings","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0045","doi-asserted-by":"crossref","first-page":"E1618","DOI":"10.1073\/pnas.1716871115","article-title":"Restoring GABAergic inhibition rescues memory deficits in a Huntington\u2019s disease mouse model","volume":"115","author":"Dargaei","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrn3819","article-title":"Cation-chloride cotransporters in neuronal development, plasticity and disease","volume":"15","author":"Kaila","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0060","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1523\/JNEUROSCI.1245-12.2012","article-title":"Activity-dependent regulation of inhibition via GAD67","volume":"32","author":"Lau","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0065","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/cercor\/bht322","article-title":"GAD67 deficiency in parvalbumin interneurons produces deficits in inhibitory transmission and network disinhibition in mouse prefrontal cortex","volume":"25","author":"Lazarus","year":"2015","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0070","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00415-004-0461-9","article-title":"Cognitive changes in patients with Huntington\u2019s disease (HD) and asymptomatic carriers of the HD mutation","volume":"251","author":"Lemiere","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0075","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0080","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1126\/science.224459","article-title":"[3H]GABA binding in brains from Huntington\u2019s chorea patients: altered regulation by phospholipids?","volume":"205","author":"Lloyd","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0024-3205(77)90085-6","article-title":"Alterations in 3H-GABA binding in Huntington\u2019s chorea","volume":"21","author":"Lloyd","year":"1977","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon I of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0095","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneur.1978.00500350032006","article-title":"Huntington\u2019s disease. Cerebrospinal fluid GABA levels in at-risk individuals","volume":"35","author":"Manyam","year":"1978","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2011.12.034","article-title":"Developmentally altered inhibition in Ts65Dn, a mouse model of Down syndrome","volume":"1440","author":"Mitra","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0105","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","article-title":"Cognitive impairment in Huntington disease: diagnosis and treatment","volume":"11","author":"Paulsen","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.ne.19.030196.000455","article-title":"Trinucleotide repeats in neurogenetic disorders","volume":"19","author":"Paulson","year":"1996","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0120","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1471-4159.1982.tb08697.x","article-title":"Human CSF GABA concentrations: revised dowd for controls, but not decreased in huntington\u2019s chorea","volume":"38","author":"Perry","year":"1982","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/874387","article-title":"Hippocampal neurogenesis, cognitive deficits and affective disorder in huntington\u2019s disease","volume":"2012","author":"Ransome","year":"2012","journal-title":"Neural Plast"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(80)90231-0","article-title":"Benzodiazepine receptors: the effect of GABA on their characteristics in human brain and their alteration in Huntington\u2019s disease","volume":"199","author":"Reisine","year":"1980","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199009063231013","article-title":"Brain GABA levels in asymptomatic Huntington\u2019s disease","volume":"323","author":"Reynolds","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0140","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2010.09.012","article-title":"Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease","volume":"41","author":"Simpson","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2015.00267","article-title":"Pharmacological correction of excitation\/inhibition imbalance in Down syndrome mouse models","volume":"9","author":"Souchet","year":"2015","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jnnp.56.5.487","article-title":"Neuronal loss in the hippocampus in Huntington\u2019s disease: a comparison with HIV infection","volume":"56","author":"Spargo","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuron.2009.12.007","article-title":"Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant Huntingtin","volume":"65","author":"Twelvetrees","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0170","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nbd.2012.02.015","article-title":"Disrupted GABAAR trafficking and synaptic inhibition in a mouse model of Huntington\u2019s disease","volume":"46","author":"Yuen","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2019.02.007_bb0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.physiol.64.092501.114547","article-title":"Short-term synaptic plasticity","volume":"64","author":"Zucker","year":"2002","journal-title":"Annu Rev Physiol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219301071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219301071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T14:14:19Z","timestamp":1566224059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452219301071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":35,"alternative-id":["S0306452219301071"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2019.02.007","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}